Synthesis and antitumoral evaluation of 7-chloro-4-quinolinylhydrazones derivatives.

Authors: Montenegro RC,Lotufo LV,de Moraes MO,Pessoa Cdo Ó,Rodrigues FA,Bispo Mde L,Cardoso LN,Kaiser CR,de Souza MV,
Address: Laboratório de Genética Humana e Médica, Universidade Federal do Pará, Belém, PA, Brazil.
Journal: Med Chem.


Publication: 2011 Nov;7(6):599-604.

abstract

A series of twenty-one 7-chloro-4-quinolinylhydrazones derivatives (3a-u) have been synthesized and evaluated for their cytotoxic potential against three cancer cell lines using MTT assay. The compounds 3b, 3e, 3f, 3h, 3j, 3n, 3r and 3u displayed more than 90% of growth inhibition (GI) and they were selected for in vitro anticancer activities evaluation against four human cancer cell lines. These results were expressed as the concentrations that induce 50% inhibition of cell growth (IC50) in μg/mL. Considering that, compounds 3b, 3e, 3h, 3n, 3r and 3u exhibited good cytotoxic activity against at least three cancer cell lines (0.7967-4.200 μg/mL). In general, we observed that the presence of electron-withdrawing groups in the benzene ring is important for the anticancer activity in this series, such as fluorine (3h), chlorine (3b) amd bromine (3e) groups in meta position and nitro group (3r) in para position. These derivatives could be considered interesting start points to develop a new anticancer drug and confirm the potential of chloroquine derivatives as lead compounds in anticancer drug discovery.



Related Articles
Potential antitumor agents. 37. Synthesis and antitumor activity of guanylhydrazones from imidazo[2,1-b]thiazoles and from the new heterocyclic system thiazolo[2',3':2,3]imidazo[4,5-c]quinoline.
J Med Chem. 2005
Potential antitumor agents. 37. Synthesis and antitumor activity of guanylhydrazones from imidazo[2,1-b]thiazoles and from the new heterocyclic system thiazolo[2',3':2,3]imidazo[4,5-c]quinoline.
Andreani A, Granaiola M, Leoni A, Locatelli A, Morigi R, Rambaldi M, Lenaz G, Fato R, Bergamini C, Farruggia G. J Med Chem. 2005 Apr 21; 48(8):3085-9.
Discovery of 1-benzoyl-3-cyanopyrrolo[1,2-a]quinolines as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 2: Structure-activity relationships of the 4-, 5-, 6-, 7- and 8-positions.
Bioorg Med Chem Lett. 2009
Discovery of 1-benzoyl-3-cyanopyrrolo[1,2-a]quinolines as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 2: Structure-activity relationships of the 4-, 5-, 6-, 7- and 8-positions.
Kemnitzer W, Kuemmerle J, Jiang S, Sirisoma N, Kasibhatla S, Crogan-Grundy C, Tseng B, Drewe J, Cai SX. Bioorg Med Chem Lett. 2009 Jul 1; 19(13):3481-4. Epub 2009 May 8.
Synthesis and biological evaluation of indolyl chalcones as antitumor agents.
Bioorg Med Chem Lett. 2010
Synthesis and biological evaluation of indolyl chalcones as antitumor agents.
Kumar D, Kumar NM, Akamatsu K, Kusaka E, Harada H, Ito T. Bioorg Med Chem Lett. 2010 Jul 1; 20(13):3916-9. Epub 2010 May 13.
Synthesis and anticancer evaluation of some new hydrazone derivatives of 2,6-dimethylimidazo[2,1-b][1,3,4]thiadiazole-5-carbohydrazide.
Eur J Med Chem. 2003
Synthesis and anticancer evaluation of some new hydrazone derivatives of 2,6-dimethylimidazo[2,1-b][1,3,4]thiadiazole-5-carbohydrazide.
Terzioglu N, Gürsoy A. Eur J Med Chem. 2003 Jul-Aug; 38(7-8):781-6.
New class of potent antitumor acylhydrazone derivatives containing furan.
Eur J Med Chem. 2010
New class of potent antitumor acylhydrazone derivatives containing furan.
Cui Z, Li Y, Ling Y, Huang J, Cui J, Wang R, Yang X. Eur J Med Chem. 2010 Dec; 45(12):5576-84. Epub 2010 Sep 17.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.